Updating results

229 results

Sort: Relevance | Date

Biosimilar medicines (KTT15)

The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

Key therapeutic topic Published February 2016 Last updated February 2018

Anticoagulants, including direct-acting oral anticoagulants (DOACs) (KTT16)

This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on anticoagulants , including direct-acting oral anticoagulants (DOACs). It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published February 2016 Last updated September 2019

Acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI (KTT17)

This document summarises the evidence base on the use of medicines in people with or at increased risk of acute kidney injury . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published February 2016 Last updated September 2019

Multimorbidity and polypharmacy (KTT18)

This document summarises the evidence base on multimorbidity and polypharmacy . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2017 Last updated September 2019

Type 2 diabetes mellitus: medicines optimisation priorities (KTT12)

This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated September 2019

Laxatives (KTT1)

The key therapeutic topic laxatives has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance .

Key therapeutic topic Published January 2015

Non-steroidal anti-inflammatory drugs (KTT13)

The key therapeutic topic non-steroidal anti-inflammatory drugs has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated February 2018

Minocycline (KTT11)

The key therapeutic topic minocycline has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance .

Key therapeutic topic Published January 2015

Wound care products (KTT14)

This document summarises the evidence base on wound care products . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated September 2019

Psychotropic medicines in people with learning disabilities whose behaviour challenges (KTT19)

This document summarises the evidence base on psychotropic medicines in people with learning disabilities whose behaviour challenges . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2017 Last updated September 2019

Renin-angiotensin system drugs: dual therapy (KTT2)

The key therapeutic topic renin-angiotensin system drugs: dual therapy has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated February 2016

Safer insulin prescribing (KTT20)

This document summarises the evidence base on safer insulin prescribing . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2017 Last updated September 2019

Medicines optimisation in chronic pain (KTT21)

This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2017 Last updated September 2019

Chemotherapy dose standardisation (KTT22)

This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published February 2018 Last updated September 2019

Shared decision making (KTT23)

This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .

Key therapeutic topic Published March 2019 Last updated September 2019

Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide (KTT24)

This document summarises the evidence base on suicide prevention: optimising medicines and reducing access to medicines as a means of suicide . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published March 2019 Last updated September 2019

Lipid-modifying drugs (KTT3)

This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated September 2019

Asthma: medicines safety priorities (KTT5)

This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated September 2019

Hypnotics (KTT6)

This document summarises the evidence base on hypnotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated September 2019

Antipsychotics in people living with dementia (KTT7)

This document summarises the evidence base on antipsychotics in people living with dementia . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated September 2019

First-choice antidepressant use in adults with depression or generalised anxiety disorder (KTT8)

The key therapeutic topic first-choice antidepressant use in adults with depression or generalised anxiety disorder has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated February 2016

Antimicrobial stewardship: prescribing antibiotics (KTT9)

This document summarises the evidence base on antimicrobial stewardship: prescribing antibiotics . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

Key therapeutic topic Published January 2015 Last updated September 2019

Three-day courses of antibiotics for uncomplicated urinary tract infection (KTT10)

The key therapeutic topic 3-day courses of antibiotics for uncomplicated urinary tract infection has been retired from the 2017 update of medicines optimisation: key therapeutic topics. Key points have been incorporated into the antimicrobial stewardship topic. See the key therapeutic topic antimicrobial stewardship: prescribing antibiotics for more information.

Key therapeutic topic Published January 2015

Omega-3 fatty acid supplements (KTT4)

The key therapeutic topic omega-3 fatty acid supplements has been incorporated into the key therapeutic topic lipid-modifying drugs. See lipid-modifying drugs for more information.

Key therapeutic topic Published January 2015

The Juxta CURES adjustable compression system for treating venous leg ulcers (MIB25)

Advice on the use of the Juxta CURES adjustable compression system for treating venous leg ulcers to aid local decision-making

Medtech innovation briefing Published March 2015

The PediGuard for placing pedicle screws in spinal surgery (MIB26)

Advice on the use of the PediGuard for placing pedicle screws in spinal surgery to aid local decision-making

Medtech innovation briefing Published March 2015

Xpert GBS test for the intrapartum detection of group B streptococcus (MIB28)

Advice on the use of the Xpert GBS test for the intrapartum detection of group B streptococcus (GBS) colonisation in pregnant women...

Medtech innovation briefing Published April 2015

LipiFlow thermal pulsation treatment for dry eyes caused by blocked meibomian glands (MIB29)

Advice on the use of the LipiFlow thermal pulsation treatment for dry eyes caused by blocked meibomian glands to aid local decision-making

Medtech innovation briefing Published April 2015

LARS for reconstructing damaged intra-articular cruciate knee ligaments (MIB30)

Advice on the use of the LARS (ligament augmentation and reconstruction system) for reconstructing damaged intra-articular cruciate knee ligaments...

Medtech innovation briefing Published May 2015

Peptest for diagnosing gastro‑oesophageal reflux (MIB31)

Advice on the use of the Peptest for diagnosing gastro-oesophageal reflux disease (GORD) to aid local decision-making

Medtech innovation briefing Published May 2015

BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis (MIB32)

Advice on the use of the BD MAX Enteric Bacterial Panel (EBP) for identifying pathogens in contagious gastroenteritis to aid local decision-making

Medtech innovation briefing Published July 2015

Spiral Flow peripheral vascular graft for treating peripheral arterial disease (MIB34)

Advice on the use of the Spiral Flow peripheral vascular (PV) graft for treating peripheral arterial disease (PAD) to aid local decision-making

Medtech innovation briefing Published July 2015

Thermogard XP for therapeutic hypothermia after cardiac arrest (MIB37)

Advice on the use of the Thermogard XP system for treating therapeutic hypothermia after cardiac arrest to aid local decision-making

Medtech innovation briefing Published September 2015

i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)

Advice on the use of the i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department to aid local decision-making

Medtech innovation briefing Published September 2015

ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment (MIB39)

Advice on the use of ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment to aid local decision-making

Medtech innovation briefing Published September 2015

The RhinoChill intranasal cooling system for reducing temperature after cardiac arrest (MIB4)

Advice on the use of the RhinoChill intranasal cooling system for reducing temperature after cardiac arrest to aid local decision-making

Medtech innovation briefing Published February 2014

PulmoVista 500 for monitoring ventilation in critical care (MIB203)

Advice on the use of PulmoVista 500 for monitoring ventilation in critical care to aid local decision making

Medtech innovation briefing Published December 2019

Plus Sutures for preventing surgical site infection (MIB204)

NICE has developed a medtech innovation briefing (MIB) on Plus Sutures for preventing surgical site infection

Medtech innovation briefing Published February 2020

National Early Warning Score systems that alert to deteriorating adult patients in hospital (MIB205)

NICE has developed a medtech innovation briefing (MIB) on National Early Warning Score systems that alert to deteriorating adult patients in hospital

Medtech innovation briefing Published February 2020

The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system (MIB21)

Advice on the use of The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system..

Medtech innovation briefing Published February 2015

Shiley Endotracheal Tube with TaperGuard Cuff for intensive care patients at risk of ventilator‑associated pneumonia (MIB22)

Advice on the use of Shiley Endotracheal Tube with TaperGuard Cuff for patients at risk of ventilator-associated pneumonia to aid local decision-making

Medtech innovation briefing Published March 2015

The Epidrum for aiding access to the epidural space (MIB23)

Advice on the use of the Epidrum for aiding access to the epidural space to aid local decision-making

Medtech innovation briefing Published March 2015

Active B12 assay for diagnosing vitamin B12 deficiency (MIB40)

Advice on the use of the Active B12 assay for diagnosing vitamin B12 deficiency to aid local decision-making

Medtech innovation briefing Published September 2015

PROPATEN heparin-bonded vascular graft for peripheral arterial disease (MIB42)

Advice on the use of the PROPATEN heparin-bonded vascular graft for treating peripheral arterial disease to aid local decision-making

Medtech innovation briefing Published October 2015

ATEC system for vacuum-assisted breast biopsy (MIB43)

Advice on the use of the ATEC system for vacuum-assisted breast biopsy to aid local decision-making

Medtech innovation briefing Published November 2015

AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35)

Advice on the use of the AliveCor Heart Monitor and AliveECG (Kardia Mobile) app for detecting atrial fibrillation (AF) to aid local decision-making

Medtech innovation briefing Published August 2015

Visensia for early detection of deteriorating vital signs in adults in hospital (MIB36)

Advice on the use of the Visensia for early detection of deteriorating vital signs in adults in hospital to aid local decision-making

Medtech innovation briefing Published August 2015

PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection (MIB200)

Advice on the use of PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection to aid local decision making

Medtech innovation briefing Published December 2019

eXroid for internal haemorrhoids (MIB201)

Advice on the use of eXroid, using direct current electrotherapy to blood vessels of internal haemorrhoid to shrink haemorrhoids, to aid local decision making

Medtech innovation briefing Published December 2019

LQD Spray for treating acute and chronic wounds (MIB202)

Advice on the use of LQD Spray (spray-on dressing containing modified biopolymer chitosan FH02) for treating acute/chronic wounds to aid local decision making

Medtech innovation briefing Published December 2019